JP2022512128A5 - - Google Patents

Info

Publication number
JP2022512128A5
JP2022512128A5 JP2021532111A JP2021532111A JP2022512128A5 JP 2022512128 A5 JP2022512128 A5 JP 2022512128A5 JP 2021532111 A JP2021532111 A JP 2021532111A JP 2021532111 A JP2021532111 A JP 2021532111A JP 2022512128 A5 JP2022512128 A5 JP 2022512128A5
Authority
JP
Japan
Prior art keywords
methyl
hydroxy
azaspiro
decane
carbonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021532111A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022512128A (ja
Filing date
Publication date
Priority claimed from GBGB1819937.2A external-priority patent/GB201819937D0/en
Priority claimed from GBGB1904339.7A external-priority patent/GB201904339D0/en
Priority claimed from GBGB1911311.7A external-priority patent/GB201911311D0/en
Application filed filed Critical
Priority claimed from PCT/GB2019/053457 external-priority patent/WO2020115501A1/en
Publication of JP2022512128A publication Critical patent/JP2022512128A/ja
Publication of JP2022512128A5 publication Critical patent/JP2022512128A5/ja
Pending legal-status Critical Current

Links

JP2021532111A 2018-12-06 2019-12-06 医薬化合物およびユビキチン特異的プロテアーゼ19(usp19)阻害剤としてのその使用 Pending JP2022512128A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB1819937.2 2018-12-06
GBGB1819937.2A GB201819937D0 (en) 2018-12-06 2018-12-06 Pharmaceutical compounds
GBGB1904339.7A GB201904339D0 (en) 2019-03-28 2019-03-28 Pharmaceutical compounds
GB1904339.7 2019-03-28
GBGB1911311.7A GB201911311D0 (en) 2019-08-07 2019-08-07 Pharmaceutical compounds
GB1911311.7 2019-08-07
PCT/GB2019/053457 WO2020115501A1 (en) 2018-12-06 2019-12-06 Pharmaceutical compounds and their use as inhibitors of ubiquitin specific protease 19 (usp19)

Publications (2)

Publication Number Publication Date
JP2022512128A JP2022512128A (ja) 2022-02-02
JP2022512128A5 true JP2022512128A5 (cg-RX-API-DMAC7.html) 2023-01-11

Family

ID=68887435

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021532111A Pending JP2022512128A (ja) 2018-12-06 2019-12-06 医薬化合物およびユビキチン特異的プロテアーゼ19(usp19)阻害剤としてのその使用

Country Status (12)

Country Link
US (1) US20220033397A1 (cg-RX-API-DMAC7.html)
EP (1) EP3890829A1 (cg-RX-API-DMAC7.html)
JP (1) JP2022512128A (cg-RX-API-DMAC7.html)
KR (1) KR20210102285A (cg-RX-API-DMAC7.html)
CN (1) CN113365696A (cg-RX-API-DMAC7.html)
AU (1) AU2019393162A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021010644A2 (cg-RX-API-DMAC7.html)
CA (1) CA3121376A1 (cg-RX-API-DMAC7.html)
IL (1) IL283706A (cg-RX-API-DMAC7.html)
MX (1) MX2021006540A (cg-RX-API-DMAC7.html)
SG (1) SG11202105913RA (cg-RX-API-DMAC7.html)
WO (1) WO2020115501A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201801562D0 (en) * 2018-01-31 2018-03-14 Almac Diagnostics Ltd Pharmaceutical compounds
GB202104097D0 (en) * 2021-03-24 2021-05-05 Almac Discovery Ltd Pharmaceutical compounds
GB202311227D0 (en) 2023-07-21 2023-09-06 Almac Discovery Ltd Pharmaceutical compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO111096A0 (en) * 1996-07-18 1996-08-08 Fujisawa Pharmaceutical Co., Ltd. New compound
US7217710B2 (en) 2001-10-02 2007-05-15 Smithkline Beecham Corporation Substituted pyrazolopyrimidines
EP2565186A1 (en) * 2011-09-02 2013-03-06 Hybrigenics S.A. Selective and reversible inhibitors of ubiquitin specific protease 7
TWI698436B (zh) * 2014-12-30 2020-07-11 美商佛瑪治療公司 作為泛素特異性蛋白酶7抑制劑之吡咯并及吡唑并嘧啶
MA41291A (fr) * 2014-12-30 2017-11-07 Forma Therapeutics Inc Dérivés de la pyrrolotriazinone et de l'imidazotriazinone en tant qu'inhibiteurs de la protéase spécifique de l'ubiquitine n° 7 (usp7) pour le traitement d'un cancer
HK1248221A1 (zh) * 2015-02-05 2018-10-12 Forma Therapeutics, Inc. 异噻唑啉酮类,吡唑并嘧啶酮类和吡咯并嘧啶酮作为泛蛋白特异性蛋白酶7抑制剂
EP3253765A1 (en) * 2015-02-05 2017-12-13 Forma Therapeutics, Inc. Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors
EP3253738A1 (en) * 2015-02-05 2017-12-13 Forma Therapeutics, Inc. Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
FR3052452B1 (fr) * 2016-06-10 2018-06-22 Les Laboratoires Servier Nouveaux derives de piperidinyle, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PL3468971T3 (pl) * 2016-06-10 2020-08-10 Les Laboratoires Servier Nowe pochodne (hetero)arylo-piperydynylowe, sposoby ich wytwarzania oraz zawierające je kompozycje
GB201612938D0 (en) * 2016-07-26 2016-09-07 Almac Discovery Ltd Pharmaceutical compounds
GB201801562D0 (en) * 2018-01-31 2018-03-14 Almac Diagnostics Ltd Pharmaceutical compounds

Similar Documents

Publication Publication Date Title
JP2021525220A5 (cg-RX-API-DMAC7.html)
AU2023356610A1 (en) Tethered heterocyclic inhibitors of kras g12c mutant proteins and uses thereof
AU2018201903B2 (en) SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1,2-a]PYRIDINE-3-CARBOXAMIDE COMPOUNDS AS TYPE III RECEPTOR TYROSINE KINASE INHIBITORS
JP2024502433A5 (cg-RX-API-DMAC7.html)
RU2020127848A (ru) Производные 4-гидроксипиперидина и их применение в качестве ингибиторов убиквитин-специфической протеазы 19 (usp19)
KR102003532B1 (ko) 새로운 (헤테로)아릴-치환된-피페리디닐 유도체, 이의 제조를 위한 방법 및 이를 함유하는 약학적 조성물
JP6432624B2 (ja) 3環性ヘテロ環化合物及びjak阻害剤
JP2022543689A (ja) Shp2阻害剤
JP2019535664A5 (cg-RX-API-DMAC7.html)
JP2016525092A5 (cg-RX-API-DMAC7.html)
NZ586913A (en) Bicyclic derivatives for use in the treatment of androgen receptor associated conditions
JP2021504380A5 (cg-RX-API-DMAC7.html)
KR20160003328A (ko) Btk 활성의 억제제로서의 헤테로아릴 피리돈 및 아자-피리돈 화합물
JP2015523387A5 (cg-RX-API-DMAC7.html)
JP2015522002A5 (cg-RX-API-DMAC7.html)
AU2011344001A1 (en) Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors
WO2019158731A1 (en) Pharmaceutical 6,5 heterobicyclic ring derivatives
CN110475777A (zh) 用于治疗和预防细菌感染的新吡啶并[2,3-b]吲哚化合物
WO2025230878A1 (en) Macrocyclic compounds as modulators of kras and uses thereof
TW202334166A (zh) 螺三環ripk1抑制劑及其使用方法
RU2021119602A (ru) Фармацевтические композиции и их применение в качестве ингибиторов убиквитин-специфической протеазы 19 (usp19)
FR3052451A1 (cg-RX-API-DMAC7.html)
JP2025516566A5 (cg-RX-API-DMAC7.html)
NZ757607A (en) Heterocyclylmethylidene derivatives and their use as modulators of mglur5 receptors
NZ757607B2 (en) HETEROCYCLYLMETHYLIDENE DERIVATIVES AND THEIR USE AS MODULATORS OF mGluR5 RECEPTORS